Staff Details

Lakshmi Ananth, M.S.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22329
F: (650) 617-2639

Paul Barnett, Ph.D.
Director
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22475
F: (650) 617-2639

Barnett's research focuses on the cost-effectiveness of healthcare inventions, determination of the cost of healthcare in the absence of billing data, and economic modeling in support of healthcare policy decisions. He is a health economist at the VA Center for healthcare Evaluation, the VA Cooperative Studies Program Coordinating Center, and the Treatment Research Center at the University of California, San Francisco.

He is also Consulting Assistant Professor in the Department of Health Research and Policy at Stanford University School of Medicine. His health services research focuses on the cost-effectiveness of treatments for substance abuse disorders. He is applying methods used to evaluate medical care interventions to the substance abuse field. A model of the effect of methadone maintenance on healthcare costs and survival determined the treatment is at least a cost-effective as other healthcare interventions provided to injection drug users. This work is being extended via a dynamic model of the HIV epidemic being developed in collaboration with Stanford Professor Margaret Brandeau. They are also combining the results of a meta-analysis of trials comparing buprenorphine to methadone with the HIV model to determine the potential cost-effectiveness of buprenorphine maintenance.

Barnett is assisting investigators in the University of California, San Francisco Treatment Research Center evaluate a medication management intervention for HIV-positive drug abusers, among other interventions. He is assisting a VA trial testing if a matching strategy improves hospital and community- based residential treatment for substance abuse patients with psychiatric disorders.

He has lead a team that completed an economic analysis of data from the VA Non-Q-wave Infarction Strategies in Hospital (VANQWISH) trial, which demonstrated that a conservative, ischemia-guided strategy was safe and effective for management of non-Q-wave myocardial infarction. The conservative strategy was shown to be more cost-effective (click here for article), a result that is helping to shape clinical opinion on the best treatment for heart attack (click here for editorial). He also serves as the VA economist on a trial evaluating PTCA in the context of intensive medical therapy in the treatment of all but the very highest risk patients with coronary heart disease. He is leading a team that is studying whether Positron Emission Tomography is cost-effective enough to justify its adoption for the diagnosis lung cancer.

Shuo Chen, Ph.D.
Research Health Science Specialist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22737
F: (650) 617-2639

Shuo Chen is a Research Associate in the VA Health Economics Resource Center and the Palo Alto Cooperatives Studies Program Coordinating Center. His research has included studies of the cost-effectiveness of management of cardiac disease, and the evaluation of the cost of VA substance abuse treatment programs. He is the principal staff on the HERC average cost product line. He has his Ph.D. in Social Demography from Kansas State University where he studied cancer morbidity among farmers.

Adam Chow, B.A.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22061
F: (650) 617-2639

Vilija Joyce, M.S.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x23852
F: (650) 617-2639

Samuel King, M.S., M.Div.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x23859
F: (650) 617-2639

Ciaran Phibbs, Ph.D.
Health Economist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22813
F: (650) 617-2639

Dr. Phibbs is a health economist at the Center for Health Care Evaluation and the Cooperative Studies Program Coordinating Center, a Consulting Associate Professor in the Department of Health Research and Policy, Stanford University School of Medicine, and a Research Associate, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University. His own VA research projects have focused on the demand for VA healthcare and how travel distance and the availability of non-VA alternatives influence veterans use of VA care. In more general terms, his research focuses on the hospital costs and competition. Much of this work has looked at how travel distance effects hospitals, and methods for defining hospital markets. Dr. Phibbs also has a long standing interest in neonatal care. Since coming to VA he has continued to conduct some neonatal related research with non-VA funding. This work is currently focusing on how the competition-driven expansion of neonatal intensive care units has effected neonatal mortality.

Mark Smith, Ph.D.
Health Economist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22945
F: (650) 617-2639

Mark Smith performs research in three areas: cost-effectiveness of health interventions, micro-costing methods, and the economic impact of trauma and violence. He is Associate Director of the VA Health Economics Resource Center (HERC), where he leads the development of guidelines for research using micro-costing methods. He is also a member of the VA Cooperative Studies Program (CSP), serving as health economist for clinical studies. Beyond VA, Smith is an associate of the Center for Primary Care Outcomes and Research (PCOR) at Stanford University.

A major area of Smith’s research is the economic impacts of trauma and violence. Using data from Washington State, Smith quantified the impact of violent abuse on the earnings of poor women. A later study investigated the impact of abuse on poor women's use of public assistance programs. Smith collaborates with the VA National Center for PTSD in research on military sexual trauma (MST). He also serves as health economist for VA CSP trial #519, which investigates integration of smoking-cessation therapy with PTSD therapy.

A second research interest is the economics of telehealth interventions. Smith is currently estimating the potential cost savings from using telehealth in the treatment of veterans with spinal cord injuries who develop pressure ulcers. He also directs the economic analysis for a clinical trial of telephone follow-up for veterans recently discharged from inpatient treatment for PTSD.

Prior to joining VA, Smith studied pharmacoeconomics and health services at The Medstat Group (now Thomson Reuters). His research there investigated the cost implications of using alternative antipsychotics, health promotion programs to reduce health risks or hospitalization, and the role of price increases in explaining rising national drug spending.

Pon Su, M.S.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22955
F: (650) 617-2639

Todd Wagner, Ph.D.
Health Economist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22048
F: (650) 617-2639

I'm a health economist with the Palo Alto VA. At the VA, my primary position is with the Health Economics Resource Center, but I am also affiliated with the Center for healthcare Evaluation and the Cooperative Studies Coordinating Center. The Palo Alto VA has a close relationship with Stanford University. In particular, I am affiliated with the Center for Health Policy (CHP) and the Center for Primary Care and Outcomes Research (PCOR).

In addition to my VA work, I am interested in the evaluation of consumer health information and the cost of research administration (including IRBs). Other areas of interest include cost-effectiveness analysis, quality of life measurement, and access to care for multicultural populations.

I received my Ph.D. in Health Economics from the Health Services and Policy Analysis Program at the University of California, Berkeley in 1999.

• VA IRB Evaluations

• C I R B Evaluation

• Consumer health information
• The cost of Institutional Review Boards (IRBs)
• Second opinions
• Willingness to pay
• Urinary incontinence

Wei Yu, Ph.D.
Health Economist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x23157
F: (650) 617-2639

Dr. Yu's research interests include determination of healthcare costs, cost-effective analysis, risk adjustment method, healthcare financing policy and healthcare delivery structure under different institutional structures, cultural backgrounds, and economic capacities.

Dr. Yu is a health economist at the VA Health Economics Resource Center, VA Center for healthcare Evaluation, and the VA Cooperative Studies Program Coordinating Center. He is also a fellow at the Center for Health Policy and Center for Primary Care Outcomes and Research at Stanford University.

In determination of healthcare costs, he investigated costs of nursing homes in South Carolina as well as use of hospital service and intensive care for the elderly. As Research Faculty of the healthcare Financing Administration (HCFA) Research Data Assistance Center, he taught Medicare reimbursement methods, and prepared training databases for health services researchers on how to identify Medicare expenses and hospital costs in HCFA files.

He is currently leading the product line at the VA Health Economics Resource Center to evaluate the Decision Support System, a cost accounting system developed to identify costs of healthcare services provided by the VA. He recently analyzed effects of age and chronic diseases on healthcare costs. He is currently evaluating cost-effectiveness of treatment strategies for HIV/AIDs patients who have failed second runs of anti-retrovirals.

Dr. Yu has analyzed healthcare costs and utilization during the last year of life, including differences in hospice use, place of death, and cause of death between decedents enrolled in a managed care plan and a fee-for-service plan. He also compared Medicare expenses between decedents who used hospice services during the last year of life with those who did not. Dr. Yu is expanding this research to the VA Health Care System. He has studied long-term care use near the end of life among VA patients.

In international studies, Dr. Yu has provided consultation on healthcare financing policy, structure of the community healthcare system, and reimbursement methods for hospital services in China in separate projects funded by the United Nations Development Programme and the Ford Foundation. He is currently coordinating a China-US post- doctoral training program funded by the National Institute of Health at Stanford. His recent research is comparing risk diversification of the employer-based health insurance systems between US and China.

Carol Ashton, M.D., M.P.H.
Director
Houston Center for Quality of Care and Utilization Studies
VA Medical Center
2002 Holcombe Blvd.
Houston, TX 77030
P: (713) 794-8652
F: (713) 794-7292

I am interested in and currently working on several projects that pertain to capitation and risk adjustment issues.

Patsi Sinnott, P.T., Ph.D., M.P.H.
Health Economist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x23955
F: (650) 617-2639

Ann Hendricks, Ph.D.
Chief, Health Economics Section
Center for Health Quality, Outcomes and Economic Research
Edith Nourse Rogers Memorial Veterans Hospital (152)
200 Springs Road
Bedford, MA 01730
P: (781) 687-2963
F: (781) 687-3106

Dr. Hendricks is Chief of the Economics Research Section at the Center for Health Quality, Outcomes and Economic Research (CHQOER) and Associate Professor of Health Services at Boston University School of Public Health. She is currently the principal investigator for a VA service directed project to evaluate variations in patient severity as they relate to VA budgets and co-PI (with Gary Nugent of the Cincinnati VAMC) on an evaluation of VA costs. She is also co-investigator on an NCI-funded project at Massachusetts General Hospital to study the cost-effectiveness of home care for cancer patients with febrile neutropenia. She is currently the PI on a Congressionally mandated evaluation of VA's long term care programs. She is also a member of an advisory committee examining budget issues related to VA's research support budget. She consults to other CHQOER researchers on economic analyses related to telemedicine, ambulatory care, and costs of care in VHA. She serves on dissertation committees for Ph.D candidates at Brandeis University's Heller Graduate School of Social Welfare. She has taught Cost Effectiveness and Decision Analysis at the Boston University School of Public Health.

Charles L. Bennett, M.D., Ph.D.
Senior Research Associate/ Associate Professor
Lakeside VAMC/Northwestern University
Medical Sciences Building
400 East Ontario Street
Chicago, IL 60611
P: (312) 943-6600 x4354
F: (312) 640-2496

Dr. Bennett's work addresses costs of care for cancer therapies, with a focus on new therapeutics, devices, and technologies. He currently is leading an effort, in collaboration with the International Blood and Marrow Transplant Registry, to evaluate costs of stem cell transplantation at 18 centers in the United States. He also has led early efforts in this field, with extensive publications from the University of Nebraska experience as well as in conjunction with newer approaches including allogeneic peripheral blood stem cell transplantation and adjunctive use of hematopoietic colony stimulating factors. Other cost studies involve maximal androgen blockade therapy for prostate cancer, and amifostine for ovarian cancer, and liposomal doxorubicin for HIV-related Kaposi's sarcoma.

Selected Publications

Bennett CL, Golub RM, Calhoun E et al. Cost-Utility Assessment of Amifostine in First-line Therapy for Ovarian Cancer. Int J Gyn Cancer 1998; in press.

Waters TM, Bennett CL, Pajeau TS et al. Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: What do we know? Bone Marrow Transplant 1998; 21: 641-650.

Bennett CL, Armitage JL, Armitage GO, et al. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: Results from the University of Nebraska 1987-1991. J Clin Oncol 1995;13:969-973.

Douglas D. Bradham, Dr. P.H.
Director
VISN 5 HSR&D Center
VA Maryland Health Care System
10 North Greene Street
Baltimore, MD 21201
P: (410) 706-0065
F: (410) 706-0098

Jim Burgess, Ph.D.
Economist
VA Management Science Group


, MA 01730
P: (781) 687-2488
F: (781) 687-2376

Margaret Byrne, Ph.D.
Research Economist
Houston VA HSR&D Center of Excellence
Baylor College of Medicine
VAMC (152), Research 110T, 2002 Holcombe Blvd.
Houston, TX 77030
P: (713) 794-7615
F: (713) 794-7103

My research focuses on the use of financial incentive for affecting patient/healthcare consumers behavior. For example, the use of financial incentives for increasing cadveric organ donation rates has just been instituted in Pennsylvania. My research begins with an economic model to determine the most effective and efficient method for financial compensation. In addition, ethical analyses will explore the use of these financial incentives in terms of whether they may be coercive, exploitative or commodify the human body. In another line of research, I am exploring the relationship between primary care utilization and hospitalization rates for ambulatory care sensitive conditions.

Selected Publications

Byrne MM, Thompson P. 1999. Death and Dignity: Terminal Illness and the Market for Non?Treatment. Forthcoming: Journal of Public Economics

Byrne MM, Ashton CM. 1999. Incentives for Vertal Integration in Healthcare: The Effect of Reimbursement System. Journal of Healthcare management 44(1).

Kathleen Carey, Ph.D.
Economist
VA Management Science Group
Edith Nourse Rogers Memorial Veterans Hospital
200 Springs Road
Bedford, MA 01730
P: (781) 687-2140
F: (781) 687-2376

Kathleen Carey, Ph.D. is an economist with the VA Management Science Group. Her primary research interest is the study of hospital and other healthcare costs with particular emphasis on comparing the performance of VA with the private sector. She has expertise in applying state-of-the-art econometric models to VA and nonfederal hospital cost analyses. Currently, she is leading the MSG effort to examine the effects of managed care on VA healthcare costs and comparing that to managed care effects outside the VA.

Selected Publications

"On Measuring the Hospital Cost/Quality Trade-off", 1999, (co-authored with James Burgess), Health Economics, forthcoming.

"Stochastic Demand for Hospitals and Optimizing >Excess= Bed Capacity", 1998, Journal of Regulatory Economics, 14: 165-187.

"A Panel Data Design for Estimation of Hospital Cost Functions," 1997, Review of Economics & Statistics, LXXIX: 443-453.

"Using Seminonparametric Methods to Model Hospital Cost Functions: The Multi-Product Asymptotically Ideal Model", 1994, (co-authored with Gary Koop), The Journal of Productivity Analysis, 5: 141-159.

"A Multilevel Modeling Approach to Analysis of Patient Costs Under Managed Care" (under review)

"Hospital Costing: Experience from the VHA,"(co-authored with James Burgess) (under review)

"Hospital Cost Containment and Length of Stay: An Econometric Analysis" (under review)

Michael Chapko, Ph.D.
Associate Director
NW Hepatitis C Resource Center
VA Puget Sound HCS
1660 South Columbian Way (152)
Seattle, WA 98108
P: (206) 764-2821
F: (206) 764-2859

Martin P. Charns, D.B.A.
Director
Management and Decision and Research Center
VA Medical Center (152-M)
150 South Huntington Avenue
Boston, MA 02130
P: (617) 278-4433
F: (617) 278-4438

Louis DeNino, Ph.D.
CARES Consultant
VSSC (10Ns7) Houston VAMC
Director's Office
2002 Holcombe Blvd.
Houston, TX 77030
P: (713) 794-7489
F: (713) 794-7038

Stephen D. Flach, M.D., Ph.D.
Researcher
Division of General Internal Medicine at University of Iowa College of Medicine
200 Hawkins Dr.

Iowa City, IA 52242
P: (319) 384-8266
F: (319) 356-3086

John Fortney, Ph.D.
Research Health Scientist
HSR&D Center for Mental Health and Outcomes Research
VA Medical Center (152NLR)
2200 Ft. Roots Drive
North Little Rock, AR 72114-1706
P: (501) 257-1726
F: (501) 257-1749

My research interests focus on how access to treatment impacts 1) engagement in care, 2) sustained involvement in care, 3) process/quality of care, 4) outcomes and 5) costs.

Selected Publications

Fortney J. Rost K. and Zhang M. The Impact of Geographic Accessibility on the Intensity and Quality of Depression Treatment. Medical Care, 37(9):884-93, 1999.

Fortney J. Booth B. and Curran G. Do Patients with Alcohol Dependence Use More Services? A Comparative Analysis with other Chronic Disorders. Alcoholism: Clinical and Experimental Research 23(1):127-133, 1999.

Fortney J. Owen R. and Clothier J. Impact of Travel Distance on the Disposition of Patients Presenting for Emergency Psychiatric Care. Journal of Behavioral Health Services & Research 26(1):104-108, 1999.

Fortney J. Booth B. Zhang M. Humphrey J. and Wiseman E. Controlling for Selection Bias in the Evaluation of Alcoholics Anonymous as Aftercare Treatment. Journal of Studies on Alcohol 59:690-697, 1998.

Fortney J. Rost K. and Zhang M. A Joint Choice Model of the Decision to Seek Depression Treatment and Choice of Provider Sector. Medical Care 36(3):307-320, 1998.

Fortney J. Lancaster AE. Owen R. and Zhang M. Geographic Market Areas for Psychiatric and Medical Outpatient Treatment. Journal of Behavioral Health Services & Research 25(1):108-116, 1998.

Fortney J. Booth B. Smith GR. Variation Among VA Hospitals in Length of Stay for treatment of Depression. Psychiatric Services 47(6):608-613, 1996.

Fortney J. Booth B. Blow F. Bunn J. Cook C. The Effects of Travel Barriers and Age on the Utilization of Alcoholism Treatment Aftercare. American Journal of Drug and Alcohol Abuse 21(3):391-406, 1995.

John Gardner, Ph.D.
Health Services Researcher
Center for Health Quality, Outcomes and Economic Research
Edith Nourse Rogers Memorial Veterans Hospital (152)
200 Springs Road
Bedford, MA 01730
P: (781) 687-3677
F: (781) 687-3106

Linda Harpe
VISN 9 DSS Coordinator
VA MidSouth Healthcare Network
1310 24th Avenue South

Nashville, TN 37212
P: (615) 867-6174
F: (615) 340-2386

Although I am not a researcher, I conduct cost analyses for the Network using the VA DSS database.

Ronnie D. Horner, Ph.D.
Program Director, Health Disparities Research
OMHR/OD/NINDS/NIH
6001 Executive Blvd.
NSC 2149
Bethesda, MD 20892-9535
P: (301) 496-2581
F: (301) 594-5929

Geoffery Joyce, Ph.D.
Associate Economist, RAND Research Scientist
University of California San Diego and VA San Diego Healthcare System
3350 La Jolla Village Drive, 111N-1

San Diego, CA 92161
P: (310) 393-0411 x6779
F: (858) 552-4321

Stephen Kendall
Director of Development
VHA Allocation Resource Center
100 Grandview Road
Suite 114
Braintree, MA 02184
P: (781) 849-1837 x34
F: (781) 849-0360

We do produce series of reports on an ongoing basis that show costs and volumes. Three of these are the tracking of cost on enrollment, the cost and workload for the VERA Allocation system, and producing unit cost reports that measure cost and staff per casemix adjusted work.

Sarah Krein, Ph.D., R.N.
Research Scientist
Center for Practice Management and Outcomes Research
VA Medical Center (11H)
P.O. Box 130170
Ann Arbor, MI 48113-0170
P: (734) 769-7100 x 6224
F: (734) 761-2939

Primary research areas include improving care delivery, quality, efficiency and outcomes for individuals with diabetes and other chronic illness and issues related to cost-effectiveness, quality measurement and provider profiling.

Hwai-Tai C. Lam, Ph.D.
Health System Specialist
VA Grater LA Healthcare System
11301 Wilshire Blvd

Los Angeles, CA 90073
P: (310) 478-3711 x40430
F: (310) 474-0644

Laura Lehner, Ph.D.
Researcher
VA Management Science Group
200 Springs Rd.

Bedford, MA 01730
P: (781) 687-2386
F: (781) 687-2376

Chuan-Fen Liu, Ph.D.
Investigator
Health Services Resarch and Development Center of Excellence, & Dept. of Health Services U of Washington
VA Puget Sounds Health Care System - HSR&D (152)
1660 S. Columbian Way
Seattle, WA 98108
P: (206) 764-2587
F: (206) 764-2935

Matthew L. Maciejewski, Ph.D.
Health Research Scientist
Center for Health Services Research in Primary Care
Durham VA Medical Center
508 Fulton Street
Durham, NC 27705
P: (919) 286-0411 x5198
F:

Larry Manheim, Ph.D.
Research Associate
Midwest Center for Health Services and Policy Research
Hines VA Hospital (151H)
5th Avenue at Roosevelt Road
Hines, IL 60141-5000
P: (847) 491-5102
F: (847) 491-2202

Jeff McCombs, Ph.D.
Professor, Researcher
University of Southern California
1540 E. Alcazar St. CHP-140

Los Angeles, CA 90089-9044
P: (323) 442-1465
F: (323) 442-1462

Gary Nugent, M.H.C.A.
Director
Cincinnati VA Medical Center
3200 Vine Street

Cincinnati, OH 45220
P: (513) 475-6300
F:

Previous studies have attempted to compare the costs of VA healthcare services to the private sector. Most found that VA costs were somewhat lower but differences in accounting systems focus i.e. inpatient, and populations between the two systems limited their usefulness. The comparison of costs is an important question with increased interest in contracting out some or all of veteran=s healthcare. The primary objective of this proposal is to compare the cost of VA services to Medicare costs for those same services under: a) fee for service, and b) capitation. To circumvent the impact of volume on unit cost and cost shifting, we intend to capture and compare all work performed over the course of an entire fiscal year at six VA medical centers (Albuquerque, Birmingham, Cincinnati, Kansas City, Milwaukee, and Providence). This includes overhead distribution i.e. malpractice and depreciation, and Medicare non-covered services such as pharmacy, dental, and domicilliary. In order to facilitate comparison, audits of coding accuracy, utilization review, and severity have been incorporated into the study design. The VistA database will be used to generate HCFA 1500 and UB 92 pseudo bills. Inpatient reimbursement will be determined by processing discharges, in accordance with ICD-9 CM criteria, though 3M Encoders that have been installed at each site and programmed with area specific Medicare reimbursement data. Ingenix (Salt Lake City, UT) will act as the fiscal intermediary and process outpatient facility charges and professional fees using CPT-4 and HCPCS codes extracted from the VistA database. At the completion of the study it will be possible to compare cumulative costs to cumulative reimbursement by medical center and major sub-category i.e. medicine, nursing home, pharmacy or prosthetics.

Robert Ohsfeldt, Ph.D.
Professor, Researcher
Dept. of Health Management & Policy at University of Iowa
2700 Steindler Bldg.

Iowa City, IA 52242-1008
P: (319) 335-8438
F: (319) 335-9772

John Peabody, M.D., Ph.D.

General Internal Medicine
VA Greater Los Angeles Health Care System
11301 Wilshire Boulevard
Los Angeles, CA 90073
P: (310) 393-0411 x6271
F: (310) 452-6923

Dr. Peabody is a physician and a health services researcher. His areas of interest are healthcare finance, quality of care and national healthcare systems. He is on the staff of the San Francisco Veterans Affairs Hospital, the UCSF Department of Epidemiology & Biostatistics and Medicine, the UCLA School of Public Health, Department of Health Services, and is a senior scientist at RAND. His investigations are in the areas of healthcare delivery and the impact of provider incentives on the quality of services. Prior to joining the faculty at UCSF and UCLA, he worked in Asia for six years including three years as a staff epidemiologist / medical officer in WHO. Since coming to the VA, Dr. Peabody has continued to work overseas in Latin America, Eastern Europe and Asia and has developed an active research program within the VA. This work has focused on measuring the quality of care across the VA and comparing the cost and quality of care with other nearby healthcare systems. Dr. Peabody also has an active clinical practice.

Selected Publications

Boland P, White KL, Wieners WW, Peabody JW. "Information Technology and Quality in California Healthcare: An Overview of the Landscape." Healthcare Informatics. Accepted, publication pending.

Shimkhada R and Peabody JW. "Tobacco Control in India." Bulletin of the World Health Organization. January, 2003.

Luck J and Peabody JW. "Using Standardised Patients to Measure Physicians' Practice: Validation Study Using Audio Recordings." BMJ. Vol. 325 (678), September 28, 2002.

Peabody JW, and Luck J. "When Do Developing Countries Adopt Managed Care Policies and Technologies? Part I: Policies, Experience, and a Framework of Preconditions." American Journal of Managed Care. Vol. 8 (11); 997-1007, November 2002.

Peabody JW, and Luck J. "When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies." American Journal of Managed Care. Vol. 8 (12); 1093 -1103, December 2002.

Peabody JW, Robalino DA, Kim JH. "An Evaluation of Universal Health Insurance in the Elderly: Burden of Disease, Utilization, and Costs in the Republic of Korea." Journal of Aging and Health, Vol.14 No.2, 286-310, May 2002.

Dresselhaus, TR, Luck J and Peabody JW. "The Ethical Problem of False Positives: A Comparison of Standardized Patients and the Medical Record." The Journal of Medical Ethics. Vol. 28; 291-294, October 2002.

Bhatara V, Sankar R, Ununtzer J, Peabody J. "A Review of the Case for Neonatal Hypothyroidism in Developing Countries: The Example of India." Thyroid. Vol. 12 (7); 591-598, July 2002.

Nordyke R and Peabody, JW. "Market Reforms and Public Incentives: Finding a Balance in the Republic of Macedonia." Social Science and Medicine, Vol. 54 (6); 939-953, March 2002.

Dresselhaus TR, Peabody JW, Lee M, Glassman P, Luck J. "Measuring Compliance with Preventive Care Guidelines: A Comparison of Standardized Patients, Clinical Vignettes and the Medical Record." Journal of General Internal Medicine. Vol. 15 (11);782-88, November 2000.

Glassman PA, Peabody JW, O'Gara E, and Luck J. "Using Standardized Patients to Measure Quality: Evidence from the Literature and a Prospective Study." The Joint Commission Journal in Quality Improvement, Vol. 26 (11);644-653, November 2000.

Luck J, Peabody JW, Dresselhaus TR, Lee M, and Glassman PA. "How Well Does Chart Abstraction Measure Quality? A Prospective Comparison of Standardized Patients with the Medical Record." The American Journal of Medicine, Vol.108:642-649, 2000.

Peabody JW, Luck J, Glassman PA, Dresselhaus TR, Lee M. "Comparison of Vignettes, Standardized Patients, and Chart Abstraction: A Prospective Validation Study of 3 Methods for Measuring Quality." JAMA, 283(13):1715-1722, April 5, 2000.

Luck J and Peabody JW. "Improving the Public Sector: Can Reengineering Boost Efficiency and Effectiveness at a VA Medical Center?" Health Care Management Review, 25(2):34-44, 2000.

Peabody JW. "Measuring the Social Responsiveness of Medical Schools: Setting the Standards." Academic Medicine, 74:S59-S68, 1999.

Peabody JW and Luck J. "How Far Down the Managed Care Road? A Comparison of Primary Care Outpatient Services in a Veteran's Affairs Medical Center and a Capitated Mutispecialty Group Practice." Archives of Internal Medicine, 158:2291-2299, 1998.

Peabody JW, Gertler PJ, and Leibowitz A. "The Policy Implications of Better Structure and Process on Birth Outcomes in Jamaica." (RAND Reprint #RP-826. RAND, Santa Monica, CA.) Health Policy, 43(1):1-13, January 1998.

Peabody JW, and Gertler PJ. "Are Clinical Criteria Just Proxies for Socioeconomic Status? A Study of Low Birthweight in Jamaica," Journal of Epidemiology and Community Health, 51(1):90-95, 1997.

Glassman PA, Model KE, Kahan JP, Jacobson PD, and Peabody JW. "The Role of Medical Necessity and Cost-Effectiveness in Making Medical Decisions," Annals of Internal Medicine, 26(2):152-6, 1997.

Peabody JW, Lawson J, and Bickel S. "The Australian Health Care System: Are the Incentives Down Under Right Side Up?" Journal of the American Medical Association, 276(24):1944-1950, December 25,1996.

Peabody JW. "Economic Reform and Health Sector Policy: Lessons from Structural Adjustment Programs," Social Science & Medicine, 43(5):823-835, 1996.

Peabody JW, Hesketh TM, and Steinberg PS. "Translating Clinical Practice into Health Policy: An Example from China," Health Policy, 35:107-121, 1996.

Peabody JW, Ruby A, and Cannon P. "The Economics of Orphan Drug Policy in the U.S.: Can the Legislation be Improved?" PharmoEconomics, 8(5):374-384. November 1995.

Peabody JW, Yu J, Wang Y, and Bickel SR. "Letter from Taipei. Health System Reform in the Republic of China: Formulating Policy in a Market-Based Health System," JAMA, 273(10):777-781, 1995.

Peabody JW. "An Organizational Analysis of the World Health Organization: Narrowing the Gap Between Promise and Performance," Social Science and Medicine, 40(6):731-742, 1995.

Peabody JW, Lee SW, and Bickel S. "Health for All in the Republic of Korea: One Country's Experience with Implementing Universal Health Care," Health Policy, 31:29-42, 1995.

Peabody JH, Rahman O, Fox K, and Gertler P. "Calidad de la Atencion en Establecimientos Publicos y Privados de Atencion Primaria de Salud: Comparaciones Estructurales en Jamaica," Boletin de la Oficina Sanitaria Panamericana 117(3):193-212, Winter 1994. (See English version, Bulletin PAHO, 28(2):193-212.

Peabody JW, Rahman O, Fox K, and Gertler P. "Quality of Care in Public and Private Primary Health Care Facilities: Structural Comparisons in Jamaica," Bulletin of the Pan American Health Organization, 28(2):122-141, 1994.

Peabody JW, Hesketh T, and Kattwinkel J. "Creation of a Neonatology Facility in a Developing Country: Experience from a Five Year Project in China," Am J. of Perinatology,/6:401-408, Sept/Nov. 1992.

Peabody JW, and Schmitt JM. "Medical Equipment in the Peoples Republic of China: A Survey of Medical Equipment Procurement, Utilization and Maintenance in University-Affiliated Hospitals Between 1976 and 1987," Intl. J. of Technology Assessment in Health Care, 8(1):138-149, 1992.

Kaufman A, Hamilton, JD, and Peabody JW. "Medical Education in China for the 21st Century: The Context for Change," Journal of Medical Education, 22:253-260, 1988.

Insel PA, Peabody JW, et al,. "Tachyphylaxis to Isoproternol in B-adrenergic receptors," Quarterly Journal of Catecholamine Research, 1977.

Marta Render, M.D.
Chief
Pulmonary Critical Care Section (111F)
VA Medical Center
3200 Vine Street
Cincinnati, OH 45220
P: (513) 475-6366
F:

Robert Rosenheck, M.D.
Professor of Psychiatry & Public Health, Yale Medical School & Director
Northeast Program Evaluation Center (NEPEC182)
VA Connecticut Health Care System
950 Campbell Avenue
West Haven, CT 06516
P: (203) 937-3850
F: (203) 937-3433

Dr. Robert Rosenheck is the Director of VA's Northeast Program Evaluation Center, Director of the Evaluation Division of the National Center for Posttraumatic Stress Disorder (PTSD); and Professor of Psychiatry and Public Health at Yale where he is also Director of the Division of Mental Health Services and Outcomes Research. He is a nationally known mental health service researcher who is a leader in cost-effectiveness studies of behavioral health interventions. He has been Co-Chairman of three multi-site VA Cooperative Studies on the cost-effectiveness of new medications and is responsible for the monitoring and evaluation of several hundred specialized VA programs devoted to the care of veterans suffering from PTSD, homeless veterans, and veterans who suffer from severe and persistent mental illnesses. His cost-effectiveness studies of VA's specialized PTSD programs have played a major role in transforming the way PTSD is treated in VA, and he has published widely on the subject outcomes monitoring and service system evaluation. He has been a prime architect of national VA collaborative programs with both the Department of Housing and Urban Development and the Social Security Administration. He also directs the client-level evaluation of the 5-year, 18-site ACCESS program for homeless mentally ill Americans, for the Substance Abuse and Mental Health Services Administration of the Department of Health and Human Services. He has published more than 300 scientific papers.

Anne Sales, Ph.D.
Researcher
Northwest Center for Outcomes Research in Older Adults
VA Puget Sounds Health Care System (152)
1660 South Columbian Way
Seattle, WA 98108
P: (206) 764-2068
F: (206) 764-2935

I am currently involved in 2 active projects, and the Ischemic Heart Disease Quality Enhancement Research Initiative (IHD QUERI) Research Coordinating Center as the Translation Coordinator.

The first major project I am Principal Investigator on is a translation project to improve the quality of care offered to veterans with ischemic heart disease (IHD). In this study, we are launching and monitoring the effects of interventions designed to speed up the rate of quality improvement. We will also be looking at costs of the interventions, and costs of secondary prevention for IHD in VA. We are actively working with 3 VISNs and approximately 20 VAMCs.

Laura Sarro, B.B.A.
CDR System Manager
Austin Automation Center
1615 East Woodward

Austin, TX 78772
P: (512) 326-6330
F: (512) 326-6738

Monica Schaefer, Pharm.D.
Director of Pharmacoeconomics
San Diego VA


San Diego, CA
P: (858) 552-8585 x3026
F:

Yujing Shen, Ph.D.
Health Economist
Center for Health Quality, Outcomes and Economic Research
Edith Nourse Rogers Memorial Veterans Hospital (152)
200 Springs Road
Bedford, MA 01730
P: (781) 687-3159
F: (781) 687-3106

Kris Siddharthan, Ph.D.
Assistant Professor
University of South Florida
Department of Health Policy & Management
13201 Bruce B. Downs Blvd, MDC 56
Tampa, FL 33612-3805
P: (813) 974-6650
F: (813) 974-6741

Diane Steffick, Ph.D.
Health Economist
HSR&D Center for Mental Health and Outcomes Research
VA Medical Center (152NLR)
2200 Ft. Roots Drive
North Little Rock, AR 72114-1706
P: (501) 257-1069
F: (501) 257-1749

Hariprasad Trivedi, M.D.
Doctor
Harry S. Truman Memorial Veterans Hospital
800 Hospital Dr.

Columbia, MO 65201
P: (573) 882-4141 Page 564
F: (573) 814-6600

David Vanness, Ph.D.
Researcher
Mayo Clinic
200 First Street, SW

Rochester, MN 55905
P: (507) 538-1240
F: (507) 284-1731

Bruce Vogel, Ph.D.
Research Health Scientist
VA Medical Center
1601 SW Archer Rd

Gainesville, FL 32608
P: (352) 376-1611 x5245
F: (352) 271-4540

I am presently working on two VA grants: (1) a mixed integer programming model of optimal geographic location for VA traumatic brain injury tratment units, and (2) an investigation of patient -specific treatment costs for VA rehabilitation patients. In this work, we are using both HERC and DSS cost data to estimate a variety of econometric models.

Andrea Shane, B.A.
Research Assistant
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22847
F: (650) 617-2639

Andrew Siroka, B.A.
Research Assistant
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22100
F: (650) 617-2639

Mistry Gage, M.P.H.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22937
F: (650) 617-2639

Christine Murray, B.A.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x27978
F: (650) 617-2639

Yoko Ogawa, B.S.
Administrative Officer
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x23763
F: (650) 617-2639

Cherisse Harden, B.A.
Research Assistant
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x27979
F: (650) 617-2639

Scott Holmstrom, B.A.
Research Assistant
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22060
F: (650) 617-2639

Jennifer Yang, M.S.
Research Associate
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x22816
F: (650) 617-2639

Jean Yoon, Ph.D.
Health Economist
Health Economics Resource Center (HERC)
VA Palo Alto Healthcare System
795 Willow Road (152 MPD)
Menlo Park, CA 94025
P: (650) 493-5000 x23157
F: (650) 617-2639

Jean Yoon is a Health Economist in the VA Health Economics Resource Center and the Cooperative Studies Program Coordinating Center. Her main research interests involve care for chronic diseases, cost-effectiveness, and socioeconomic and racial disparities in health. In her most recent research, she examined adherence to prescription drugs and its relationship to cost-sharing for drugs and health outcomes. She previously worked at UCLA, UCSF, and the Health Resources and Services Administration studying access to primary care, the safety net, and disparities in quality of cancer care. She received her Ph.D. in health services from UCLA.

• To ensure the protection of VA information, we have restricted access to certain files (denoted by the lock icon). Contact HERC to download these restricted files.

  View Patsi Sinnott's CV

  Date: 11/1/2006 | Size: 27Kb

• To ensure the protection of VA information, we have restricted access to certain files (denoted by the lock icon). Contact HERC to download these restricted files.

  View Jean Yoon's CV

  Date: 8/28/2008 | Size: 53Kb

• To ensure the protection of VA information, we have restricted access to certain files (denoted by the lock icon). Contact HERC to download these restricted files.

  View Todd Wagner's CV

  Date: 6/17/2005 | Size: 65Kb

• To ensure the protection of VA information, we have restricted access to certain files (denoted by the lock icon). Contact HERC to download these restricted files.

  View Ciaran Phibbs' CV

  Date: 5/27/2008 | Size: 35Kb

• To ensure the protection of VA information, we have restricted access to certain files (denoted by the lock icon). Contact HERC to download these restricted files.

  View Mark Smith's CV

  Date: 3/7/2007 | Size: 69Kb

Sorensen, J. L.; Haug, N. A.; Delucchi, K. L.; Gruber, V.; Kletter, E.; Batki, S. L.; Tulsky, J. P.; Barnett, P.; Hall, S.. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend 2007; 88(1):

Wagner, T. H.; Engelstad, L. P.; McPhee, S. J.; Pasick, R. J.. The costs of an outreach intervention for low-income women with abnormal Pap smears. Prev Chronic Dis 2007; 4(1):

Baker, L. C.; Afendulis, C. C.; Chandra, A.; McConville, S.; Phibbs, C. S.; Fuentes-Afflick, E.. Differences in neonatal mortality among whites and Asian American subgroups: evidence from California. Arch Pediatr Adolesc Med 2007; 161(1):

Gould, M. K.; Ananth, L.; Barnett, P. G.. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007; 131(2):

Richardson, S. S.; Sullivan, G.; Hill, A.; Yu, W.. Use of aggressive medical treatments near the end of life: differences between patients with and without dementia. Health Serv Res 2007; 42(1 Pt 1):

McFall, M.; Saxon, A. J.; Thaneemit, S.; Smith, M. W.; Joseph, A. M.; Carmody, T. P.; Beckham, J. C.; Malte, C. A.; Vertrees, J. E.; Boardman, K. D.; Lavori, P. W.. Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clin Trials 2007; 4(2):

Phibbs, C. S.; Baker, L. C.; Caughey, A. B.; Danielsen, B.; Schmitt, S. K.; Phibbs, R. H.. Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. N Engl J Med 2007; 356(21):

Frayne, S. M.; Yu, W.; Yano, E. M.; Ananth, L.; Iqbal, S.; Thrailkill, A.; Phibbs, C. S.. Gender and Use of Care: Planning for Tomorrow's Veterans Health Administration. J Womens Health (Larchmt) 2007; 16(8):

Wagner, T. H.; Richardson, S. S.; Vogel, B.; Wing, K.; Smith, M. W.. Cost of inpatient rehabilitation care in the Department of Veterans Affairs. J Rehabil Res Dev 2006; 43(7):

Hoch, J. S.; Smith, M. W.. A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data. J Trauma Stress 2006; 19(6):

Haberland, C. A.; Phibbs, C. S.; Baker, L. C.. Effect of opening midlevel neonatal intensive care units on the location of low birth weight births in California. Pediatrics 2006; 118(6):

Barnett, P. G.; Masson, C. L.; Sorensen, J. L.; Wong, W.; Hall, S.. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction 2006; 101(12):

Phibbs, C. S.; Holty, J. E.; Goldstein, M. K.; Garber, A. M.; Wang, Y.; Feussner, J. R.; Cohen, H. J.. The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care 2006; 44(1):

Schmitt, S. K.; Sneed, L.; Phibbs, C. S.. Costs of newborn care in California: a population-based study. Pediatrics 2006; 117(1):

Phibbs, C. S.; Schmitt, S. K.. Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. Early Hum Dev 2006; 82(2):

Bhandari, A.; Wagner, T.. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev 2006; 63(2):

Bundorf, M. K.; Wagner, T. H.; Singer, S. J.; Baker, L. C.. Who searches the internet for health information?. Health Serv Res 2006; 41(3 Pt 1):

Tiet, Q. Q.; Byrnes, H. F.; Barnett, P.; Finney, J. W.. A practical system for monitoring the outcomes of substance use disorder patients. J Subst Abuse Treat 2006; 30(4):

Piette, J. D.; Heisler, M.; Wagner, T. H.. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol 2006; 59(7):

Weintraub, W. S.; Barnett, P.; Chen, S.; Hartigan, P.; Casperson, P.; O'Rourke, R.; Boden, W. E.; Lewis, C.; Veledar, E.; Becker, E.; Culler, S.; Kolm, P.; Mahoney, E. M.; Dunbar, S. B.; Deaton, C.; O'Brien, B.; Goeree, R.; Blackhouse, G.; Nease, R.; Spertus, J.; Kaufman, S.; Teo, K.. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. Am Heart J 2006; 151(6):

Chen, S.; Barnett, P. G.; Sempel, J. M.; Timko, C.. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity. J Subst Abuse Treat 2006; 31(1):

Bauer, M. S.; McBride, L.; Williford, W. O.; Glick, H.; Kinosian, B.; Altshuler, L.; Beresford, T.; Kilbourne, A. M.; Sajatovic, M.. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv 2006; 57(7):

Yu, W.; Wagner, T. H.; Barnett, P. G.. Determinants of cost among people who died in VA nursing homes. Med Care Res Rev 2006; 63(4):

Stroupe, K. T.; Morrison, D. A.; Hlatky, M. A.; Barnett, P. G.; Cao, L.; Lyttle, C.; Hynes, D. M.; Henderson, W. G.. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients. Circulation 2006; 114(12):

Timko, C.; Chen, S.; Sempel, J. M.; Barnett, P. G.. Dual diagnosis patients in community or hospital care: one-year outcomes and health care utilization costs. Journal of Mental Health 2006; 15(2):

Smith, M. W.. Childhood abuse and welfare use. Review of Economics of the Household 2005; 3(4):

Hu, T, Hawthorne G, Moore K, Subak L, Versi E, Wagner T. Economics of Incontinence. Health Publication, Ltd 2005; :

Sorensen, J. L.; Masson, C. L.; Delucchi, K.; Sporer, K.; Barnett, P. G.; Mitsuishi, F.; Lin, C.; Song, Y.; Chen, T.; Hall, S. M.. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol 2005; 73(6):

Palevsky, P. M.; O'Connor, T.; Zhang, J. H.; Star, R. A.; Smith, M. W.. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials 2005; 2(5):

VanVonno, C. J.; Ozminkowski, R. J.; Smith, M. W.; Thomas, E. G.; Kelley, D.; Goetzel, R.; Berg, G. D.; Jain, S. K.; Walker, D. R.. What can a pilot congestive heart failure disease management program tell us about likely return on investment?: A case study from a program offered to federal employees. Dis Manag 2005; 8(6):

Wagner, T. H.; Chen, S.. An economic evaluation of inpatient residential treatment programs in the department of veterans affairs. Med Care Res Rev 2005; 62(2):

Russo, P. A.; Smith, M. W.; Namjoshi, M.. Health care costs for schizophrenia patients started on olanzapine versus risperidone. Am J Health Syst Pharm 2005; 62(6):

Wu, M.; Xin, Y.; Wang, H.; Yu, W.. Private and public cross-subsidization: financing Beijing's health-insurance reform. Health Policy 2005; 72(1):

Wagner, T. H.; Bundorf, M. K.; Singer, S. J.; Baker, L. C.. Free Internet access, the digital divide, and health information. Med Care 2005; 43(4):

Heisler, M.; Wagner, T. H.; Piette, J. D.. Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications?. J Behav Med 2005; 28(1):

Smith, M. W.; Schnurr, P. P.; Rosenheck, R. A.. Employment outcomes and PTSD symptom severity. Ment Health Serv Res 2005; 7(2):

Berger, M.; Wagner, T. H.; Baker, L. C.. Internet use and stigmatized illness. Soc Sci Med 2005; 61(8):

Matchar, D. B.; Jacobson, A. K.; Edson, R. G.; Lavori, P. W.; Ansell, J. E.; Ezekowitz, M. D.; Rickles, F.; Fiore, L.; Boardman, K.; Phibbs, C.; Fihn, S. D.; Vertrees, J. E.; Dolor, R.. The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS). J Thromb Thrombolysis 2005; 19(3):

Hu, T. W.; Wagner, T. H.. Health-related consequences of overactive bladder: an economic perspective. BJU Int 2005; 96 Suppl 1:

Richardson, S. S.; Yu, W.. Controlling for patient case mix at the end of life: issues in identifying cause of death. JAMA 2005; 294(7):

Masson, C. L.; Barnett, P. G.; Sees, K. L.; Delucchi, K. L.; Rosen, A.; Wong, W.; Hall, S. M.. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction 2004; 99(6):

Heisler, M.; Wagner, T. H.; Piette, J. D.. Clinician identification of chronically ill patients who have problems paying for prescription medications. Am J Med 2004; 116(11):

Bakera, L. C.; Phibbs, C. S.; Guarino, C.; Supina, D.; Reynolds, J. L.. Within-year variation in hospital utilization and its implications for hospital costs. J Health Econ 2004; 23(1):

Bhutani, V. K.; Johnson, L. H.; Jeffrey Maisels, M.; Newman, T. B.; Phibbs, C.; Stark, A. R.; Yeargin-Allsopp, M.. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24(10):

Wagner, T. H.; Cruz, A. M.; Chadwick, G. L.. Economies of Scale in Institutional Review Boards. Med Care 2004; 42(8):

Kerr, E. A.; Gerzoff, R. B.; Krein, S. L.; Selby, J. V.; Piette, J. D.; Curb, J. D.; Herman, W. H.; Marrero, D. G.; Narayan, K. M.; Safford, M. M.; Thompson, T.; Mangione, C. M.. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med 2004; 141(4):

Piette, J. D.; Heisler, M.; Wagner, T. H.. Cost-related medication underuse: do patients with chronic illnesses tell their doctors?. Arch Intern Med 2004; 164(16):

Masson, C. L.; Sorensen, J. L.; Phibbs, C. S.; Okin, R. L.. Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. AIDS Care 2004; 16(6):

Cowper, D.; Yu, W.; Kuebeler, M.; Kubal, J. D.; Manheim, L. M.; Ripley, B. A.. Using GIS in government: an overview of the VHA's Healthcare Atlas, FY-2000. J Med Syst 2004; 28(3):

Yu, W.; Cowper, D.; Berger, M.; Kuebeler, M.; Kubal, J.; Manheim, L.. Using GIS to profile health-care costs of VA Quality-Enhancement Research Initiative diseases. J Med Syst 2004; 28(3):

Piette, J. D.; Heisler, M.; Wagner, T. H.. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health 2004; 94(10):

Bundorf, M. K.; Singer, S. J.; Wagner, T. H.; Baker, L.. Consumers' use of the Internet for health insurance. Am J Manag Care 2004; 10(9):

Wagner, T. H.; Goldstein, M. K.. Behavioral interventions and cost-effectiveness analysis. Prev Med 2004; 39(6):

Yu, W.; Ravelo, A.; Wagner, T. H.; Barnett, P. G.. The relationships among age, chronic conditions, and healthcare costs. Am J Manag Care 2004; 10(12):

Wagner, T. H.; Baker, L. C.; Bundorf, M. K.; Singer, S.. Use of the internet for health information by the chronically ill. Prev Chronic Dis 2004; 1(4):

Bakera, L. C.; Phibbs, C. S.; Guarino, C.; Supina, D.; Reynolds, J. L.. Within-year variation… Appendix - Formal analysis of the effects of demand variability of costs in a model with longterm and short-term contracts. J Health Econ 2004; :

Wagner, TH. Cost of Urinary Incontinence. Timely Top Med 2004; :

Piette, J. D.; Wagner, T. H.; Potter, M. B.; Schillinger, D.. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care 2004; 42(2):

Piette, J. D.; Heisler, M.; Wagner, T. H.. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care 2004; 27(2):

Smith, M. W.; Chen, S.. Current trends in outpatient pharmacy in VA specialized mental health treatment. Psychiatr Serv 2004; 55(3):

Hu, T. W.; Wagner, T. H.; Bentkover, J. D.; Leblanc, K.; Zhou, S. Z.; Hunt, T.. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 2004; 63(3):

Wagner, T. H.. Improving the decision processes of institutional review boards. JAMA 2004; 291(14):

Wagner, T. H.; Chen, S.; Barnett, P. G.. Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VA. Med Care Res Rev 2003; 60(3 Suppl):

Malkin, J. D.; Schoenbaum, M.. Estimation of encounter-level hospitalization costs: accuracy of a multivariate prediction model. Med Care Res Rev 2003; 60(3 Suppl):

Yu, W.; Wagner, T. H.; Chen, S.; Barnett, P. G.. Average cost of VA rehabilitation, mental health, and long-term hospital stays. Med Care Res Rev 2003; 60(3 Suppl):

Phibbs, C. S.; Bhandari, A.; Yu, W.; Barnett, P. G.. Estimating the costs of VA ambulatory care. Med Care Res Rev 2003; 60(3 Suppl):

Smith, M. W.; Barnett, P. G.. Direct measurement of health care costs. Med Care Res Rev 2003; 60(3 Suppl):

Smith, M. W.; Joseph, G. J.. Pharmacy data in the VA health care system. Med Care Res Rev 2003; 60(3 Suppl):

Barnett, P. G.. Determination of VA health care costs. Med Care Res Rev 2003; 60(3 Suppl):

Blackhouse, G.; Goeree, R.; O'Brien, B. J.. Methods for patient-level costing in the VA system: are they applicable to Canada?. Med Care Res Rev 2003; 60(3 Suppl):

Yu, W.; Ravelo, A.; Wagner, T. H.; Phibbs, C. S.; Bhandari, A.; Chen, S.; Barnett, P. G.. Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev 2003; 60(3 Suppl):

Gould, M. K.; Sanders, G. D.; Barnett, P. G.; Rydzak, C. E.; Maclean, C. C.; McClellan, M. B.; Owens, D. K.. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003; 138(9):

Sorensen, J. L.; Dilley, J.; London, J.; Okin, R. L.; Delucchi, K. L.; Phibbs, C. S.. Case management for substance abusers with HIV/AIDS: a randomized clinical trial. Am J Drug Alcohol Abuse 2003; 29(1):

Baker, L.; Wagner, T. H.; Singer, S.; Bundorf, M. K.. Use of the Internet and E-mail for Health Care Information: Results From a National Survey. JAMA 2003; 289(18):

Wagner, T. H.; Bhandari, A.; Chadwick, G. L.; Nelson, D. K.. The cost of operating institutional review boards (IRBs). Acad Med 2003; 78(6):

Hu, T. W.; Wagner, T. H.; Bentkover, J. D.; LeBlanc, K.; Piancentini, A.; Stewart, W. F.; Corey, R.; Zhou, S. Z.; Hunt, T. L.. Estimated economic costs of overactive bladder in the United States. Urology 2003; 61(6):

Wagner, L. S.; Wagner, T. H.. The effect of age on the use of health and self-care information: confronting the stereotype. Gerontologist 2003; 43(3):

Humphreys, K.; Trafton, J.; Wagner, T. H.. The cost of institutional review board procedures in multicenter observational research. Ann Intern Med 2003; 139(1):

Schmitt, S. K.; Phibbs, C. S.; Piette, J. D.. The influence of distance on utilization of outpatient mental health aftercare following inpatient substance abuse treatment. Addict Behav 2003; 28(6):

Crown, W. H.; Olufade, A.; Smith, M. W.; Nathan, R.. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns. Value Health 2003; 6(4):

Kyriakides, T. C.; Babiker, A.; Singer, J.; Cameron, W.; Schechter, M. T.; Holodniy, M.; Brown, S. T.; Youle, M.; Gazzard, B.. An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial. Control Clin Trials 2003; 24(4):

Berger, M.; Gould, M. K.; Barnett, P. G.. The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. AJR Am J Roentgenol 2003; 181(2):

Cuellar, A. E.; Wagner, T. H.; Hu, T. W.; Peifer, K.; Kitzman, H.; Tobin, S. J.; Shih, V.; Morrow, S.. New opportunities for integrated child health systems: results from the multifaceted pre-to-three program. Am J Public Health 2003; 93(11):

Gould, M. K.; Kuschner, W. G.; Rydzak, C. E.; Maclean, C. C.; Demas, A. N.; Shigemitsu, H.; Chan, J. K.; Owens, D. K.. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003; 139(11):

Chen, S.; Smith, M. W.; Wagner, T. H.; Barnett, P. G.. Spending for specialized mental health treatment in The VA: 1995-2001. Health Aff (Millwood) 2003; 22(6):

Wagner, T. H.; Jimison, H. B.. Computerized health information and the demand for medical care. Value Health 2003; 6(1):

Wagner, T. H.; Subak, L. L.. Evaluating an incontinence intervention in nursing home residents. J Am Geriatr Soc 2003; 51(2):

Barnett, PG, Wagner T. Preface to the supplement: Frontiers in VA cost determination. Med Care Res Rev 2003; 60(3 Suppl):

Barnett, P, Lin P, Wagner T.. Estimating the cost of cardiac care provided by the hospitals of the US Department of Veterans Affairs. Cardiovascular Health Care Economics 2003; 151(6):

None. Entire Supplement. Med Care Res Rev 2003; 60(3 Suppl):

None. Table of Contents. Med Care Res Rev 2003; 60(3 Suppl):

Demakis JG. Foreward. Med Care Res Rev 2003; 60(3 Suppl):

None. Glossary. Med Care Res Rev 2003; 60(3 Suppl):

Smith, M. W.. Work and abuse among poor women: Evidence from Washington State. Research in Labor Economics 2002; 20:

Baker, L. C.; Phibbs, C. S.. Managed care, technology adoption, and health care: the adoption of neonatal intensive care. Rand J Econ 2002; 33(3):

Gould, M. K.; Maclean, C. C.; Kuschner, W. G.; Rydzak, C. E.; Owens, D. K.. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2002; 285(7):

Barnett, P. G.; Chen, S.; Boden, W. E.; Chow, B.; Every, N. R.; Lavori, P. W.; Hlatky, M. A.. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation 2002; 105(6):

Cohen, H. J.; Feussner, J. R.; Weinberger, M.; Carnes, M.; Hamdy, R. C.; Hsieh, F.; Phibbs, C.; Courtney, D.; Lyles, K. W.; May, C.; McMurtry, C.; Pennypacker, L.; Smith, D. M.; Ainslie, N.; Hornick, T.; Brodkin, K.; Lavori, P.. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002; 346(12):

Cifuentes, J.; Bronstein, J.; Phibbs, C. S.; Phibbs, R. H.; Schmitt, S. K.; Carlo, W. A.. Mortality in low birth weight infants according to level of neonatal care at hospital of birth. Pediatrics 2002; 109(5):

Max, W.; Sinnot, P.; Kao, C.; Sung, H. Y.; Rice, D. P.. The burden of osteoporosis in California, 1998. Osteoporos Int 2002; 13(6):

Emanuel, E. J.; Ash, A.; Yu, W.; Gazelle, G.; Levinsky, N. G.; Saynina, O.; McClellan, M.; Moskowitz, M.. Managed care, hospice use, site of death, and medical expenditures in the last year of life. Arch Intern Med 2002; 162(15):

Haberland, C. A.; Benitz, W. E.; Sanders, G. D.; Pietzsch, J. B.; Yamada, S.; Nguyen, L.; Garber, A. M.. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002; 110(3):

Crystal-Peters, J.; Neslusan, C. A.; Smith, M. W.; Togias, A.. Health care costs of allergic rhinitis-associated conditions vary with allergy season. Ann Allergy Asthma Immunol 2002; 89(5):

Wagner, T. H.; Hu, T. W.; Bentkover, J.; LeBlanc, K.; Stewart, W.; Corey, R.; Zhou, Z.; Hunt, T.. Health-related consequences of overactive bladder. Am J Manag Care 2002; 8(19 Suppl):

Russo, P.; Smith, M. W.; Dirani, R.; Namjoshi, M.; Tohen, M.. Pharmacotherapy patterns in the treatment of bipolar disorder. Bipolar Disord 2002; 4(6):

Levinsky, N. G.; Yu, W.; Ash, A.; Moskowitz, M.; Gazelle, G.; Saynina, O.; Emanuel, E. J.. Influence of age on Medicare expenditures and medical care in the last year of life. Jama 2001; 286(11):

Wagner, T. H.; Hu, T.; Duenas, G. V.; Kaplan, C. P.; Nguyen, B. H.; Pasick, R. J.. Does willingness to pay vary by race/ethnicity? An analysis using mammography among low-income women. Health Policy 2001; 58(3):

Barnett, P. G.; Zaric, G. S.; Brandeau, M. L.. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction 2001; 96(9):

Wagner, T. H.; Hu, T. W.; Hibbard, J. H.. The demand for consumer health information. J Health Econ 2001; 20(6):

Wagner, T. H.; Hibbard, J. H.. Who uses self-care books, advice nurses, and computers for health information?. Int J Technol Assess Health Care 2001; 17(4):

Trafton, J, Finney J, Moos RH, Willenbring M, Humphreys K, Barnett P. Effective Treatment of Opioid Dependence. Practice Matters 2001; 6:

Hui, SS. Advances in VA Health Economics Research1930. Veterans Health System Journal 2001; 6(3):

Barnett, P. G.; Rodgers, J. H.; Bloch, D. A.. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 2001; 96(5):

Chen, S.; Wagner, T. H.; Barnett, P. G.. The effect of reforms on spending for veterans' substance abuse treatment, 1993-1999. Health Aff (Millwood) 2001; 20(4):

Wagner, T. H.; Hibbard, J. H.; Greenlick, M. R.; Kunkel, L.. Does providing consumer health information affect self-reported medical utilization? Evidence from the Healthwise Communities Project. Med Care 2001; 39(8):

Wagner, T. H.; Greenlick, M. R.. When parents are given greater access to health information, does it affect pediatric utilization?. Med Care 2001; 39(8):

Ash, A. S.; Ellis, R. P.; Pope, G. C.; Ayanian, J. Z.; Bates, D. W.; Burstin, H.; Iezzoni, L. I.; MacKay, E.; Yu, W.. Using diagnoses to describe populations and predict costs. Health Care Financ Rev 2000; 21(3):

Hughes, S. L.; Weaver, F. M.; Giobbie-Hurder, A.; Manheim, L.; Henderson, W.; Kubal, J. D.; Ulasevich, A.; Cummings, J.. Effectiveness of team-managed home-based primary care: a randomized multicenter trial. Jama 2000; 284(22):

Zaric, GS, Brandeau ML, Barnett P. Methadone Maintenance and HIV Prevention: A Cost-Effectiveness Analysis. Management Science 2000; 46(8):

Hui, SS. HERC Hosts Health Economics Session. Veterans Health System Journal 2000; 5(6):

Yu, W.; Ash, A. S.; Levinsky, N. G.; Moskowitz, M. A.. Intensive care unit use and mortality in the elderly. J Gen Intern Med 2000; 15(2):

Guendelman, S.; Wagner, T. H.. Health services utilization among Latinos and white non-Latinos: results from a national survey. J Health Care Poor Underserved 2000; 11(2):

Mooney, C.; Zwanziger, J.; Phibbs, C. S.; Schmitt, S.. Is travel distance a barrier to veterans' use of VA hospitals for medical surgical care?. Soc Sci Med 2000; 50(12):

Zaric, G. S.; Barnett, P. G.; Brandeau, M. L.. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000; 90(7):

Rodgers, J. H.; Barnett, P. G.. Two separate tracks? A national multivariate analysis of differences between public and private substance abuse treatment programs. Am J Drug Alcohol Abuse 2000; 26(3):

Barnett, P. G.; Hui, S. S.. The cost-effectiveness of methadone maintenance. Mt Sinai J Med 2000; 67(5-6):

Lavori, PW, Feussner JR, Wagner T. Economic and ethical considerations in placebo controlled trails of new drugs for mood disorders. The Economics of Neuroscience 2000; 2(9):

Welch, H. G.; Johnson, D. J.; Edson, R.. Telephone care as an adjunct to routine medical follow-up. A negative randomized trial. Eff Clin Pract 2000; 3(3):

Hu, T. W.; Wagner, T. H.. Economic considerations in overactive bladder. Am J Manag Care 2000; 6(11 Suppl):

Spetz, J.; Baker, L.; Phibbs, C.; Pedersen, R.; Tafoya, S.. The effect of passing an "anti-immigrant" ballot proposition on the use of prenatal care by foreign-born mothers in California. J Immigr Health 2000; 2(4):

Patrick, D. L.; Martin, M. L.; Bushnell, D. M.; Yalcin, I.; Wagner, T. H.; Buesching, D. P.. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 1999; 53(1):

Chen, S.; DJ, Adamchak. The Effects of Filial Responsibility Expectations on Intergenerational Exchanges in Guangzhou, China. Hallym Intl J of Aging 1999; 1(2):

Swindle, R.; Lukas, C. V.; Meyer, D. A.; Barnett, P. G.; Hendricks, A. M.. Cost analysis in the Department of Veterans Affairs: consensus and future directions. Med Care 1999; 37(4 Suppl Va):

Barnett, P. G.. Review of methods to determine VA health care costs. Med Care 1999; 37(4 Suppl Va):

Menke TJ, Homan RH, Kashner TM. Determining costs in VA: research design problems and solutions illustrated with case studies. Med Care 1999; 37(4 Suppl):

Hynes, D.; Reda, D.; Giobbie-Hurder, A.; Abdellatif, M.; Weinberger, M.; Oddone, E.; Wasson, J.; Henderson, W.. Measuring costs in multisite randomized controlled trials: lessons from the VA Cooperative Studies Program. Med Care 1999; 37(4 Suppl Va):

Chapko, M. K.; Hedrick, S.. Cost as a study outcome: sensitivity of study conclusions to the method of estimating cost. Med Care 1999; 37(4 Suppl Va):

Menke, T. J.; Wray, N. P.. Use of a cost accounting system to evaluate costs of a VA special program. Med Care 1999; 37(4 Suppl Va):

Hendricks, A. M.; Remler, D. K.; Prashker, M. J.. More or less?: Methods to compare VA and non-VA health care costs. Med Care 1999; 37(4 Suppl Va):

Barnett, P. G.; Rodgers, J. H.. Use of the Decision Support System for VA cost-effectiveness research. Med Care 1999; 37(4 Suppl Va):

Wagner, T. H.; Wagner, L. S.. Who gets second opinions?. Health Aff (Millwood) 1999; 18(5):

Lightwood, J. M.; Phibbs, C. S.; Glantz, S. A.. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics 1999; 104(6):

Barnett, P. G.. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 1999; 94(4):

Barnett, P. G.. The cost-effectiveness of substance abuse treatment. Curr Psychiatry Rep 1999; 1(2):

None. Table of Contents. Med Care 1999; 37(4 Suppl):

Demakis JG. Preface. Med Care 1999; 37(4 Suppl):

Resources for Economic Evaluation of HSR&D QUERI
HSRD TRA 05-081 (2/1/2005 to 1/31/2008)

The Effect of Information Technology and Nurses and Patients in the Veterans Health Administration
Other RWJ 051136 (11/1/2004 to 10/31/2006)

Resource Center Cyber-Seminar Program Supplemental Funding
HSRD CYS 05-183 (10/1/2004 to 9/30/2006)

Integrating Clinical Practice Guidelines for Smoking Cessation into Mental Heatlh Care for Veterans with Posttraumatic Stress Disorder: Economic Analysis
CSP 519 (9/1/2004 to 9/30/2009)

Translating Research into Action for Diabetes in VA - Phase 2 (TRIAD VA2)
Other SDR 03-318 (5/1/2004 to 4/30/2005)

Cost and Cost-Effectiveness of VA Treatment of Substance Use Disorders
Other PERC (10/1/2003 to 9/30/2004)

Intensive vs. Conventional Renal Support in Acute Renal Failure
CSP 530 (9/1/2003 to 3/31/2009)

The Home International Normalized Ratio (INR) Monitor Study (THINRS)
CSP 481 (8/1/2003 to 3/30/2009)

Preference Measurement for Trial-Based Economic Evaluations
CSP 146 (7/1/2003 to 6/30/2005)

End of Life Care: Medical Treatments and Costs by Age, Race, and Region
HSRD IIR 02-189 (4/1/2003 to 3/30/2006)

Improving Coronary Prevention in a County Health System
Other R01 HL070781-01 (4/1/2003 to 3/31/2007)

Estimating the Cost of Specialized VA Treatment for Substance Use Disorders
HSRD ECN 02-236 (10/1/2002 to 9/30/2004)

Developing Patient-Specific Cost Estimates for VA Rehab Patients
Other 03047C (6/1/2002 to 3/31/2005)

Radial Artery vs. Saphenous Vein Grafts in Coronary Artery Bypass Surgery
CSP 474 (10/1/2001 to 9/30/2005)

Tri-National Trial 1: Options In Management with Anti-Retrovirals (OPTIMA) (Economics Sub-study)
CSP 512-e (1/6/2001 to 5/30/2006)

Clinical Practices and Outcomes in VA Methadone Maintenance Programs
HSRD SUS 99-026 (7/1/2000 to 6/30/2004)

Regionalization, Market Forces, and Neonatal Mortality
Other RO1 HD36914 (4/1/2000 to 3/31/2005)

Clinical Outcomes, Revascularization & Aggressive Evaluation (Courage)
CSP 424 (10/1/1999 to 10/31/2005)

Treatments for Complex Patients in New Settings
Other 2 P50 DA09253-06 (9/1/1999 to 8/31/2006)

18-F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients with Solitary Pulmonary Nodules
CSP 27 (6/1/1998 to 10/31/2005)